Trial · NCT00576420
Outcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants Achieving Hemostasis at 4 Minutes After Treatment Application at the Study Suture Line. | 4 minutes post start of treatment application | Intent to Treat | percentage of participants | NUMBER |
| PRIMARY | 90% Confidence Interval for the Percentage of Participants Achieving Hemostasis at 4 Minutes After Treatment Application at the Suture Line | 4 minutes post start of treatment application | Intent to Treat | percentage of participants | NUMBER |
| PRIMARY | Hemostasis at 4 Minutes After Treatment Application at the Suture Line by Bleeding Severity - Moderate Bleeding | 4 minutes post start of treatment application | Intent to Treat | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Achieving Hemostasis at 6 Minutes | 6 minutes post start of treatment application start | Intent to Treat | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Achieving Hemostasis at 10 Minutes | 10 minutes post start of treatment application | Intent to Treat | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Intraoperative Rebleeding After Hemostasis at the Study Suture Line | Intraoperative day 0 | Intent to Treat | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Postoperative Rebleeding After Hemostasis at the Study Suture Line | Postoperative through day 30 ± 5 | Intent to Treat | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Any Transfusion Requirement | Intraoperative (day 0) through day 30 ± 5 | Intent to Treat | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Graft Occlusions | Day 0 (procedure day) through day 30 ± 5 | Safety Analysis Set | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Infections at the Surgical Site | Day 0 (procedure day) through day 30 ± 5 | Safety Analysis Set | percentage of participants | NUMBER |
| SECONDARY | Vital Signs: Systolic and Diastolic Blood Pressure - Preoperative Baseline | Within 14 days prior to date of surgery | Safety Analysis Set | mm Hg | MEDIAN |
| SECONDARY | Percent Change in Vital Signs: Systolic and Diastolic Blood Pressure | Preoperative baseline through postoperative Day 14 | Safety Analysis Set | percent change | MEDIAN |
| SECONDARY | Vital Signs: Heart Rate - Preoperative Baseline | Within 14 days prior to date of surgery | Safety Analysis Set | Heart beats/ minute | MEDIAN |
| SECONDARY | Percent Change in Vital Signs: Heart Rate | Preoperative baseline through postoperative Day 14 | Safety Analysis Set | percent change | MEDIAN |
| SECONDARY | Vital Signs: Respiratory Rate - Preoperative Baseline | Within 14 days prior to date of surgery | Safety Analysis Set | Breaths/ minute | MEDIAN |
| SECONDARY | Percent Change in Vital Signs: Respiratory Rate | Preoperative baseline through postoperative Day 14 | Safety Analysis Set | percent change | MEDIAN |
| SECONDARY | Laboratory Values Over Time: Hemoglobin | Preoperative baseline through postoperative Day 14 | Safety Analysis Set | g/dl | MEDIAN |
| SECONDARY | Laboratory Values Over Time: Hematocrit | Preoperative baseline through postoperative Day 14 | Safety Analysis Set | percentage of red blood cells in blood | MEDIAN |
| SECONDARY | Laboratory Values Over Time: Erythrocytes | Preoperative baseline through postoperative Day 14 | Safety Analysis Set | x10^6/µl | MEDIAN |
| SECONDARY | Laboratory Values Over Time: Leukocytes, Basophils, Eosinophils, Lymphocytes, Neutrophils, and Monocytes | Preoperative baseline through postoperative Day 14 | Safety Analysis Set | x10^3/µl | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00576420/outcomes